Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Soroka University Medical Center, Beer-Sheva, Israel.
J Clin Endocrinol Metab. 2022 Jan 18;107(2):336-345. doi: 10.1210/clinem/dgab681.
Lower fasting ghrelin levels (FGL) are associated with obesity and metabolic syndrome.
We aimed to explore the dynamics of FGL during weight loss and its metabolic and adiposity-related manifestations beyond weight loss.
This was a secondary analysis of a clinical trial that randomized participants with abdominal obesity/dyslipidemia to 1 of 3 diets: healthy dietary guidelines (HDG), Mediterranean diet (MED), or green-MED diet, all combined with physical activity (PA). Both MED diets were similarly hypocaloric and included 28 g/day walnuts. The green-MED group further consumed green tea (3-4 cups/day) and a Wolffia globosa (Mankai) plant green shake. We measured FGL and quantified body fat depots by magnetic resonance imaging at baseline and after 18 months.
Among 294 participants (body mass index = 31.3 kg/m2; FGL = 504 ± 208 pg/mL; retention rate = 89.8%), lower FGL was associated with unfavorable cardiometabolic parameters such as higher visceral adipose tissue (VAT), intrahepatic fat, leptin, and blood pressure (P < 0.05 for all; multivariate models). The ∆FGL18-month differed between men (+7.3 ± 26.6%) and women (-9.2% ± 21.3%; P = 0.001). After 18 months of moderate and similar weight loss among the MED groups, FGL increased by 1.3%, 5.4%, and 10.5% in HDG, MED, and green-MED groups, respectively (P = 0.03 for green-MED vs HDG); sex-stratified analysis revealed similar changes in men only. Among men, FGL18-month elevation was associated with favorable changes in insulin resistance profile and VAT regression, after adjusting for relative weight loss (HbA1c: r = -0.216; homeostatic model of insulin resistance: r = -0.154; HDL-c: r = 0.147; VAT: r = -0.221; P < 0.05 for all). Insulin resistance and VAT remained inversely related with FGL elevation beyond that explained by weight loss (residual regression analyses; P < 0.05).
Diet-induced FGL elevation may reflect insulin sensitivity recovery and VAT regression beyond weight loss, specifically among men. Green-MED diet is associated with greater FGL elevation.
较低的空腹 ghrelin 水平(FGL)与肥胖和代谢综合征有关。
我们旨在探索减肥过程中 FGL 的动态变化及其减肥以外的代谢和肥胖相关表现。
这是一项临床试验的二次分析,该试验将腹部肥胖/血脂异常的参与者随机分为 3 种饮食组之一:健康饮食指南(HDG)、地中海饮食(MED)或绿色-MED 饮食,均结合身体活动(PA)。两种 MED 饮食均热量较低,且均包含 28 克/天的核桃。绿色-MED 组还饮用绿茶(3-4 杯/天)和 Mankai 浮萍植物绿色奶昔。我们在基线和 18 个月时测量 FGL,并通过磁共振成像定量测量体脂肪蓄积。
在 294 名参与者中(体重指数 = 31.3 kg/m2;FGL = 504 ± 208 pg/mL;保留率 = 89.8%),较低的 FGL 与不良的心血管代谢参数相关,如更高的内脏脂肪组织(VAT)、肝内脂肪、瘦素和血压(所有参数 P < 0.05;多变量模型)。男性的 ∆FGL18 个月差异为(+7.3 ± 26.6%),女性为(-9.2% ± 21.3%;P = 0.001)。在 MED 组进行中等且相似的 18 个月减重后,HDG、MED 和绿色-MED 组的 FGL 分别增加了 1.3%、5.4%和 10.5%(绿色-MED 与 HDG 相比 P = 0.03);性别分层分析仅显示男性有类似的变化。在男性中,FGL18 个月的升高与胰岛素抵抗谱和 VAT 消退的有利变化相关,调整了相对体重减轻(HbA1c:r = -0.216;胰岛素抵抗稳态模型:r = -0.154;HDL-c:r = 0.147;VAT:r = -0.221;所有 P < 0.05)。胰岛素抵抗和 VAT 与 FGL 升高之间的关系仍然与体重减轻以外的因素有关(残留回归分析;P < 0.05)。
饮食诱导的 FGL 升高可能反映了减肥以外的胰岛素敏感性恢复和 VAT 消退,特别是在男性中。绿色-MED 饮食与更高的 FGL 升高有关。